SIRT1 inhibits ferroptosis of granulosa cells in polycystic ovarian syndrome.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder among adolescent females and women of reproductive age. Ferroptosis is a newly recognized form of programmed cell death characterized by lipid peroxidation, which is iron-dependent and involves an elevation in cellular reactive oxygen species (ROS). In this study, we investigated the role of ferroptosis-related genes in PCOS through integrative bioinformatics and experimental validation. Differential expression analysis of Gene Expression Omnibus (GEO) datasets, combined with machine learning and Cytoscape, identified SIRT1 as a candidate gene linked to ferroptosis. Analysis of GEO datasets showed that SIRT1 expression was decreased by 1.32-fold in PCOS granulosa cells compared with controls (p < 0.05). Subsequently, we utilized scRNA-seq data analysis and performed cell communication analyses for a more in-depth understanding. Functional assays revealed that SIRT1 overexpression or pharmacological activation by SRT1720 significantly decreased lipid peroxidation and reactive oxygen species levels, thereby alleviating ferroptosis (p < 0.05). Mechanistically, co-immunoprecipitation indicated that SIRT1 interacted with Nrf2, and molecular docking suggested potential SIRT1-binding compounds. Collectively, these findings indicate that SIRT1 suppresses ferroptosis in granulosa cells via Nrf2 deacetylation, providing new insight into PCOS pathogenesis and suggesting SIRT1 as a potential therapeutic target.